Literature DB >> 12393576

Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation.

Ursula Reuter1, Joachim Roesler, Christian Thiede, Ansgar Schulz, Carl Friedrich Classen, Uta Oelschlagel, Klaus-Michael Debatin, Wilhelm Friedrich.   

Abstract

Complete interferon-gamma receptor 1 (IFNgammaR1) deficiency is a primary immunodeficiency disease characterized by high susceptibility to recurrent, severe mycobacterial and other intracellular infections. We here report the first successful treatment of the disorder by bone marrow transplantation (BMT). The 8-year-old girl had suffered from recurrent mycobacterial infections in the past and had developed liver cirrhosis with portal hypertension. For conditioning, fractionated total body irradiation (TBI) was used in combination with cyclophosphamide and antithymocyte globulin (ATG). The patient received red cell-depleted bone marrow from her HLA-identical sister. The transplantation course was uneventful and 4 years later, the child remains in excellent clinical condition and free of mycobacterial infections. She has stable mixed lymphohematopoietic chimerism after repeat T-cell transfusions. Liver disease has not further deteriorated. This experience shows that correction of IFNgammaR1 deficiency is possible by BMT and complications of the disease can be controlled.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393576     DOI: 10.1182/blood-2002-02-0433

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Disseminated Mycobacterium Avium Infection in a Child with Complete Interferon-γ Receptor 1 Deficiency due to Compound Heterozygosis of IFNGR1 for a Subpolymorphic Copy Number Variation and a Novel Splice-Site Variant.

Authors:  Grazia Bossi; Edoardo Errichiello; Orsetta Zuffardi; Piero Marone; Vincenzina Monzillo; Daniela Barbarini; Antonio Vergori; Lorenzo Andrea Bassi; Gaetana Anna Rispoli; Mara De Amici; Marco Zecca
Journal:  J Pediatr Genet       Date:  2019-11-04

Review 2.  Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency.

Authors:  Peter Olbrich; Maria Teresa Martínez-Saavedra; José Maria Perez-Hurtado; Cristina Sanchez; Berta Sanchez; Caroline Deswarte; Ignacio Obando; Jean-Laurent Casanova; Carsten Speckmann; Jacinta Bustamante; Carlos Rodriguez-Gallego; Olaf Neth
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

Review 4.  Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-gamma receptor 1 deficiency.

Authors:  Carolina Prando; Stéphanie Boisson-Dupuis; Audrey V Grant; Xiao-Fei Kong; Jacinta Bustamante; Jacqueline Feinberg; Ariane Chapgier; Yoann Rose; Lucile Jannière; Elena Rizzardi; Qiuping Zhang; Catherine M Shanahan; Louis Viollet; Stanislas Lyonnet; Laurent Abel; Ezia Maria Ruga; Jean-Laurent Casanova
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

5.  A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.

Authors:  Xiao-Fei Kong; Guillaume Vogt; Ariane Chapgier; Christophe Lamaze; Jacinta Bustamante; Carolina Prando; Anny Fortin; Anne Puel; Jacqueline Feinberg; Xin-Xin Zhang; Pauline Gonnord; Ulla M Pihkala-Saarinen; Mikko Arola; Petra Moilanen; Laurent Abel; Matti Korppi; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Hum Mol Genet       Date:  2009-10-31       Impact factor: 6.150

6.  Two patients with complete defects in interferon gamma receptor-dependent signaling.

Authors:  Jeroen G Noordzij; Nico G Hartwig; Frank A W Verreck; Sandra De Bruin-Versteeg; Tjitske De Boer; Jaap T Van Dissel; Ronald De Groot; Tom H M Ottenhoff; Jacques J M Van Dongen
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.317

7.  Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.

Authors:  Nioosha Nekooie-Marnany; Caroline Deswarte; Vajiheh Ostadi; Bahram Bagherpour; Elaheh Taleby; Mazdak Ganjalikhani-Hakemi; Tom Le Voyer; Hamid Rahimi; Jérémie Rosain; Zahra Pourmoghadas; Saba Sheikhbahaei; Razieh Khoshnevisan; Daniel Petersheim; Daniel Kotlarz; Christoph Klein; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Jacinta Bustamante; Roya Sherkat
Journal:  J Clin Immunol       Date:  2018-09-25       Impact factor: 8.317

Review 8.  Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-γ receptor-1 deficiency.

Authors:  Neslihan Edeer Karaca; Stephanie Boisson-Dupuis; Güzide Aksu; Jacinta Bustamante; Gulsen Kandiloglu; Nazan Ozsan; Mine Hekimgil; Jean-Laurent Casanova; Necil Kutukculer
Journal:  Immunotherapy       Date:  2012-11       Impact factor: 4.196

9.  Vaccination-related Mycobacterium bovis BCG infection.

Authors:  Anna Liberek; Maria Korzon; Ewa Bernatowska; Magdalena Kurenko-Deptuch; Marlena Rytlewska
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Partial IFN-γR2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.

Authors:  Marcela Moncada-Vélez; Rubén Martinez-Barricarte; Dusan Bogunovic; Xiao-Fei Kong; Lizbeth Blancas-Galicia; Cengiz Tirpan; Guzide Aksu; Quentin B Vincent; Bertrand Boisson; Yuval Itan; Noé Ramírez-Alejo; Satoshi Okada; Alexandra Y Kreins; Vanessa L Bryant; Jose Luis Franco; Mélanie Migaud; Sara Espinosa-Padilla; Marco Yamazaki-Nakashimada; Francisco Espinosa-Rosales; Necil Kutukculer; Laurent Abel; Jacinta Bustamante; Guillaume Vogt; Jean-Laurent Casanova; Stéphanie Boisson-Dupuis
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.